Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development

Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development

The use of vaccines for cancer therapy is a promising immunotherapeutic strategy that has been shown to be effective against various cancers. Vaccines directly target tumors but their efficacy against glioblastoma multiforme (GBM) remains unclear. Immunotyping that classifies tumor samples is consid...

Full description

Bibliographic Details
Main Authors: Han Lin, Kun Wang, Yuxin Xiong, Liting Zhou, Yong Yang, Shanwei Chen, Peihong Xu, Yujun Zhou, Rui Mao, Guangzhao Lv, Peng Wang, Dong Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Immunology
Subjects:
mRNA vaccine
glioblastoma
tumor immune microenvironment
immunotyping
WGCNA
landscape
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.773264/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.773264/full

Similar Items